findmyKOL

Hillard Lazarus, MD

Enriched profile

Professor Emeritus of Medicine, Division of Hematology and Oncology · Case Western Reserve University School of Medicine

ORCIDNPI
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyHematology / OncologyFocusHematopoietic Stem Cell Transplantation+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1990–2018

Hillard Lazarus is Professor Emeritus of Medicine, Division of Hematology and Oncology at Case Western Reserve University School of Medicine. OpenAlex indexes 1,054 publications with 50,317 citations (h-index 110); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Hillard M. Lazarus, MD, is Professor Emeritus of Medicine, Division of Hematology and Oncology at Case Western Reserve University School of Medicine. The public record shows 1,054 publications with 50,317 citations (h-index 110), centered on Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 10 companies, 5 NIH-funded awards (1990–2018).

  • Most recent indexed publication: 2026 · Bone marrow transplantation
  • Top research focus: Hematopoietic Stem Cell Transplantation
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)7 trialsMultiple Myeloma6 trialsMDS / MPN4 trialsLymphoma3 trialsLeukemia, Myeloid, Acute3 trialsHematologic Neoplasms2 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma2 trialsLymphoma, Non-Hodgkin2 trialsHodgkin Disease2 trialsGraft vs Host Disease1 trialCoronary Occlusion1 trialLeukemia, Lymphocytic, Chronic, B-Cell1 trialLymphoma, Follicular1 trialBurkitt Lymphoma1 trialLymphoma, B-Cell, Marginal Zone1 trialLymphoma, B-Cell1 trialWaldenstrom Macroglobulinemia1 trialMycosis Fungoides1 trialSezary Syndrome1 trialLymphoma, T-Cell, Peripheral1 trialLymphoma, T-Cell1 trialLeukemia, Erythroblastic, Acute1 trialLeukemia, Megakaryoblastic, Acute1 trialIntraocular Lymphoma1 trialLeukemia, Promyelocytic, Acute1 trialLeukemia, T-Cell1 trialGranuloma1 trialLymphomatoid Granulomatosis1 trialAutoimmune Diseases1 trialImmune System Diseases1 trialAnemia, Aplastic1 trialTic Disorders1 trialBreast Cancer1 trial

Research focus

OpenAlex concept fingerprint
Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Drugs & molecules

across trials, industry payments and publications
Leukinegeneric · SargramostimClinical trialsIndustry payments71Publications2FluconazoleClinical trials1Industry paymentsPublications2VoriconazoleClinical trials1Industry paymentsPublications1

Works with

trial sponsors and companies reporting payments
Seagen Inc.Clinical trialsIndustry payments92Partner Therapeutics, Inc.Clinical trialsIndustry payments71Amgen Inc.Clinical trialsIndustry payments50

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,054publications

Distinct works indexed by OpenAlex, matched via ORCID; 42 in PubMed.

50,317citations

Total citations across indexed works.

110h-index

Hirsch index (OpenAlex). i10-index 553.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 1990–2018

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 27 Aug 2026

5 NIH research awards on record, funded 19902018 per NIH RePORTER. The latest:

31 more award records behind the reveal.Reveal →

Congress activity

Updated 27 Aug 2026

57 congress contributions (2004–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/hillard-lazarus-2aa96022

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/in/hillard-lazarus-9596771a7

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/in/hillard-lazarus-md-facp-b657b87

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
3 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    apps.winshipcancer.emory.edu/admin/Event/5009/lymphoid-malignancy-conference---hillard-m-lazarus-md-facp---hepatic-veno-occlusive-disease-vodsinusoidal-obstruction-syndrome-sos-in-hematopoietic-cell-transplant-recipients

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apps.winshipcancer.emory.edu
  • Other

    case.edu/cancer/sites/default/files/2019-05/Case_CCC_ASCO_2019.pdf

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →case.edu
  • Other

    thetartan.org/2011/10/24/special/lazarus

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thetartan.org
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Rochester School of Medicine and Dentistry

    1974
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicianwiki.com
  • BS

    Engineering, Carnegie Mellon University

    1970
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cmu.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.case.edu

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    Blood Reviews (Elsevier)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
  • Editor-in-Chief

    Best Practice & Research Clinical Haematology (Elsevier)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencedirect.com
  • First Chair

    ECOG (Eastern Cooperative Oncology Group) Blood and Marrow Transplant Committee (17 years)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →library.cmu.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.